Aristotle University Of Thessaloniki (AUTH)
Ο ρόλος της λιπονεκτίνης και της βισφατίνης στη ινσουλινοαντίσταση και στη μη-αλκοολική νόσο λιπώδους ήπατος
Abstract
dc:descriptionIntroduction: Adipose tissue has emerged as endocrine tissue by producing various adipocytokines and cytokines. Although their specific role has not been defined yet, adipocytokines and cytokines seem to affect insulin sensitivity and inflammation, thereby playing a key-role in insulin resistance syndrome and related morbidities, including nonalcoholic fatty liver disease (NAFLD). Aims: The main aims of the present study were the following: 1) measurements of total and high molecular weight (HMW) adiponectin, and visfatin in insulin resistance syndrome and NAFLD Greek patients, 2) investigation of their correlation with other serological parameters, possibly involved in the pathogenesis of NAFLD, and 3) investigation of the presence of independent predictors of nonalcoholic steatohepatitis (NASH) and possibly the introduction of a potential non-invasive model predicting NASH. Methods: Thirty patients with biopsy-proven NAFLD and 24 healthy controls matched for gender, age, body mass index (BMI) and waist circumference, were consequently recruited in the present series. History, physical examination and fasting blood samples for serological analysis were obtained the same day, before liver biopsy. Based on liver histologic data, the patients were further divided into those with simple nonalcoholic fatty liver (NAFL) and those with nonalcoholic steatohepatitis (NASH). Conclusions: The results of the present series revealed that serum total and HMW adiponectin, but not visfatin, levels were decreased in patients with NAFL or NASH compared with the controls, though were similar between NAFL and NASH patients. Total, but not HMW, adiponectin could predict hepatic fibrosis independently from gender, age and BMI. There was no correlation between adiponectin and visfatin levels, a finding also reported by populations different from NAFLD. This study launches, for the first time, the introduction of the non-invasive index, named HSENSI (Homocysteine, SGOT and Erythrocyte sedimentation rate, Nonalcoholic Steatohepatitis Index), which is based on relatively simple serum measurements (homocysteine, SGOT and erythrocyte sedimentation rate) and can effectively predict NASH with sensitivity 73.3% and specificity 86.7%.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2012
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Polyzos, Stergios
- Πολύζος, Στέργιος
Subjects
dc:subject × 20- Μη αλκοολική λιπώδη νόσος του ήπατος
- Μη αλκοολική στεατοηπατίτιδα
- Ινσουλινοαντίσταση
- Λιπώδης ιστός
- Λιπονεκτίνη
- Βισφατίνη
- Κυτοκερατίνη - 18
- Μη επεμβατικός δείκτης
- Nonalcoholic fatty liver disease
- Nonalcoholic steatohepatitis
- Insulin resistance
- Adipose tissue
- Adiponectin
- Visfatin
- Cytokeratin - 18
- Non invasive marker
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/28278